Editorial
doi: 10.1001/jama.2013.284665.
Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?
Affiliations
- PMID: 24449314
- PMCID: PMC4161014
- DOI: 10.1001/jama.2013.284665
Item in Clipboard
Editorial
Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?
JAMA.
2014 Jan.
No abstract available
Conflict of interest statement
Comment on
-
MicroRNA biomarkers in whole blood for detection of pancreatic cancer.JAMA. 2014 Jan 22-29;311(4):392-404. doi: 10.1001/jama.2013.284664. JAMA. 2014. PMID: 24449318
Similar articles
-
MicroRNA biomarkers in whole blood for detection of pancreatic cancer.JAMA. 2014 Jan 22-29;311(4):392-404. doi: 10.1001/jama.2013.284664. JAMA. 2014. PMID: 24449318
-
Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.Oncotarget. 2016 Jul 5;7(27):41575-41583. doi: 10.18632/oncotarget.9491. Oncotarget. 2016. PMID: 27223429 Free PMC article.
-
Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.Cell Physiol Biochem. 2016;39(5):1716-1722. doi: 10.1159/000447872. Epub 2016 Sep 19. Cell Physiol Biochem. 2016. PMID: 27639768
-
[Differential diagnosis between pancreatic carcinoma and chronic pancreatitis].Nihon Rinsho. 2006 Jan;64 Suppl 1:170-4. Nihon Rinsho. 2006. PMID: 16457243 Review. Japanese. No abstract available.
-
Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: achievements and future directions.Curr Opin Gastroenterol. 2021 Sep 1;37(5):486-490. doi: 10.1097/MOG.0000000000000765. Curr Opin Gastroenterol. 2021. PMID: 34156036 Free PMC article. Review.
Cited by
-
miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.BMC Syst Biol. 2019 Jan 21;13(1):10. doi: 10.1186/s12918-019-0680-4. BMC Syst Biol. 2019. PMID: 30665415 Free PMC article.
-
Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice.Oncotarget. 2016 Apr 19;7(16):22700-10. doi: 10.18632/oncotarget.8148. Oncotarget. 2016. PMID: 27009811 Free PMC article.
-
A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.Am J Gastroenterol. 2014 Dec;109(12):1942-52. doi: 10.1038/ajg.2014.331. Epub 2014 Oct 28. Am J Gastroenterol. 2014. PMID: 25350767 Free PMC article.
-
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.Cent Eur J Immunol. 2016;41(4):392-403. doi: 10.5114/ceji.2016.65139. Epub 2017 Jan 24. Cent Eur J Immunol. 2016. PMID: 28450803 Free PMC article. Review.
-
Deciphering the role of NcRNAs in Pancreatic Cancer immune evasion and drug resistance: a new perspective for targeted therapy.Front Immunol. 2024 Nov 1;15:1480572. doi: 10.3389/fimmu.2024.1480572. eCollection 2024. Front Immunol. 2024. PMID: 39555076 Free PMC article. Review.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. - PubMed
-
- Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28(4–5):645–656. - PubMed
-
- American Cancer Society. [Accessibility verified December 26, 2013];Cancer facts and figures 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume....
-
- Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310(14):1473–1481. - PubMed
-
- Conroy T, Desseigne F, Ychou M, et al. Groupe Tumeurs Digestives of Unicancer: PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–1825. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
